Causal proportional hazards models and time-constant exposure in randomized clinical trials
From MaRDI portal
Publication:995964
DOI10.1007/s10985-005-5233-zzbMath1121.62097OpenAlexW2003283626WikidataQ49097967 ScholiaQ49097967MaRDI QIDQ995964
A. Vandebosch, Els Goetghebeur, Tom Loeys
Publication date: 10 September 2007
Published in: Lifetime Data Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s10985-005-5233-z
Applications of statistics to biology and medical sciences; meta analysis (62P10) Estimation in survival analysis and censored data (62N02)
Related Items (4)
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults ⋮ A semiparametric linear transformation model to estimate causal effects for survival data ⋮ Instrumental variable estimation of early treatment effect in randomized screening trials ⋮ Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials
Cites Work
- Unnamed Item
- Correcting for non-compliance in randomized trials using rank preserving structural failure time models
- Information and asymptotic efficiency in parametric-nonparametric models
- A Causal Proportional Hazards Estimator for the Effect of Treatment Actually Received in a Randomized Trial with All-or-Nothing Compliance
- A class of rank test procedures for censored survival data
- Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes
- Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized Treatments
- On the Effect of Treatment among Would-Be Treatment Compliers: An Analysis of the Multiple Risk Factor Intervention Trial
- Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests
This page was built for publication: Causal proportional hazards models and time-constant exposure in randomized clinical trials
